Description
JQ1 preferentially inhibited GLI1 in DAOY cells but c-MYC in HD-MB03 cells, suggesting cell-type specific BRD4-mediated transcriptional programs. This differential targeting pattern is unexplained but could reveal distinct therapeutic vulnerabilities across medulloblastoma subtypes.
Gap type: unexplained_observation Source paper: ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice. (2020, Journal of controlled release : official journal of the Controlled Release Society, PMID:32380205)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:45.613550+00:00”, “resolution_summary”: “Resolved by hypothesis h-addc0a61: Chromatin Accessibility Restoration via BRD4 Modulation. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-addc0a61”, “title”: “Chromatin Accessibility Restoration via BRD4 Modulation”, “score”: 0.225, “reason”: “26 token overlaps; entity overlap: brd4”, “analysis_id”: “SDA-2026-04-04-gap-epigenetic-reprog-b685190e”, “target_gene”: “BRD4”, “target_pathway”: “Epigenetic regulation”, “disease”: “neurodegeneration”, “composite_score”: 0.76791, “confidence_score”: 0.6, “status”: “promoted”, “pubmed_evidence_ids”: [“25303525”, “30190372”, “30842877”, “31844326”, “32220285”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5”, “title”: “While the study establishes TDP-43 triggers mtDNA release via mPTP to activate cGAS/STING, it’s unclear why this pathway preferentially affects motor neurons in ALS when TDP-43 pathology occurs in multiple cell types. Understanding this selectivity is crucial for targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.387, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-083043-759b4c5e_20260416-033650”, “title”: “The study demonstrates that apoE is absolutely required for CAA development, as apoE knockout completely prevents CAA formation. However, the specific molecular pathways by which apoE facilitates Aβ deposition in vessel walls remain unexplained, limiting therapeutic target identification.\n\nGap type: unexplained_observation\nSource paper: Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. (2003, The Journal of neuroscience : the official journal of the Society for Neuroscience, PMID:12944519)”, “score”: 0.385, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-083043-759b4c5e”, “quality_score”: 0.71, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9”, “title”: “The abstract notes that clinical presentations overlap across different myelopathy etiologies, but the mechanistic basis for this convergent phenotype is not explained. Resolving this could improve differential diagnosis and reveal common therapeutic targets.\n\nGap type: unexplained_observation\nSource paper: Uncommon inflammatory/immune-related myelopathies. (2021, J Neuroimmunol, PMID:34715593)”, “score”: 0.37, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062111-db808ee9”, “quality_score”: 0.86, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.361, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5”, “title”: “The abstract identifies APOE4 association with increased TDP-43 pathology but the mechanistic link is unexplained. This connection could reveal novel therapeutic targets since APOE4 is the strongest genetic risk factor for AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.361, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}